CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
2.535
+0.045 (1.81%)
Nov 21, 2024, 12:14 PM EST - Market open
CureVac Market Cap
CureVac has a market cap or net worth of $568.64 million as of November 21, 2024. Its market cap has decreased by -53.65% in one year.
Market Cap
568.64M
Enterprise Value
383.38M
1-Year Change
-53.65%
Ranking
Category
Stock Price
$2.54
Market Cap Chart
Since the IPO on August 14, 2020, CureVac's market cap has decreased from $9.84B to $568.64M, a decrease of -94.22%. That is a compound annual growth rate of -48.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 560.79M | -40.51% |
| Dec 29, 2023 | 942.72M | -17.82% |
| Dec 30, 2022 | 1.15B | -82.12% |
| Dec 31, 2021 | 6.42B | -55.14% |
| Dec 31, 2020 | 14.31B | 45.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 585.20M |
| ABIVAX Société Anonyme | 584.61M |
| Immunome | 579.23M |
| Tectonic Therapeutic | 576.93M |
| AnaptysBio | 576.62M |
| Varex Imaging | 574.07M |
| Mineralys Therapeutics | 563.13M |
| Simulations Plus | 562.58M |